NAS:WMGI (Netherlands) Also trade in: Delisted Germany

Wright Medical Group NV

$ 27.17 0.03 (0.11%)
Volume: 1,818,607 Avg Vol (1m): 1,468,000
Market Cap $: 3.43 Bil Enterprise Value $: 4.40 Bil
P/E (TTM): 0.00 P/B: 3.75
Earnings Power Value -2.92
Net Current Asset Value -8.79
Tangible Book -4.99
Projected FCF -8.8
Median P/S Value 26.28
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 4.1/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.14
Cash-To-Debt range over the past 10 years
Min: 0.14, Med: 0.35, Max: 1.53
Current: 0.14
0.14
1.53
Equity-to-Asset 0.32
Equity-to-Asset range over the past 10 years
Min: 0.24, Med: 0.57, Max: 0.79
Current: 0.32
0.24
0.79
Debt-to-Equity 1.24
Debt-to-Equity range over the past 10 years
Min: 0.1, Med: 0.28, Max: 1.94
Current: 1.24
0.1
1.94
Debt-to-EBITDA 13.06
Debt-to-EBITDA range over the past 10 years
Min: -22.01, Med: -2.81, Max: 93.35
Current: 13.06
-22.01
93.35
Piotroski F-Score 4
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.54
DISTRESS
GREY
SAFE
Beneish M-Score -2.46
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -0.06%
WACC 5.73%

Profitability & Growth : 5/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -0.11
Operating Margin range over the past 10 years
Min: -46.57, Med: -8.95, Max: -0.11
Current: -0.11
-46.57
-0.11
Net Margin % -20.81
Net Margin range over the past 10 years
Min: -113.05, Med: -27.15, Max: -7.84
Current: -20.81
-113.05
-7.84
ROE % -22.83
ROE range over the past 10 years
Min: -64.55, Med: -28, Max: -5.19
Current: -22.83
-64.55
-5.19
ROA % -7.03
ROA range over the past 10 years
Min: -40.3, Med: -10.07, Max: -3.73
Current: -7.03
-40.3
-3.73
ROC (Joel Greenblatt) % -0.29
ROC (Joel Greenblatt) range over the past 10 years
Min: -66.87, Med: -27.4, Max: -0.29
Current: -0.29
-66.87
-0.29
3-Year Total Revenue Growth Rate 27.30
3-Year Revenue Growth Rate range over the past 10 years
Min: -14.9, Med: -3, Max: 10
Current: 5.9
-14.9
10
3-Year EPS w/o NRI Growth Rate 25.70
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: -89.2, Med: 22.65, Max: 49.1
Current: 25.7
-89.2
49.1

» WMGI's 30-Y Financials

Financials (Next Earnings Date: 2019-08-07)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:WMGI

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 339113    SIC : 3842
Compare NAS:TNDM SZSE:300529 SZSE:002223 NAS:LIVN NAS:NUVA NYSE:GMED NAS:IART HKSE:01066 NYSE:PEN XSWX:TECN TSE:6849 NYSE:ITGR NAS:PODD NAS:CNMD OCSE:OSSR TSE:8086 TSE:3360 NAS:INGN NYSE:NVRO XSWX:MOVE
Traded in other countries TRNX.Delisted T98.Germany
Address Prins Bernhardplein 200, Amsterdam, NLD, 1097 JB
Wright Medical Group develops medical devices and products in five categories: lower extremities, upper extremities, biologics, large joints, and sport medicine, and other. Products for lower extremities include joint implants and bone fixation devices for the foot and ankle, whereas products for upper extremities include implants and devices for the shoulder, elbow, wrist, and hand. The biologics business sells products used to treat damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The large joints business sells hip and knee replacement implants. The firm's sports medicine products are used to mechanically repair tissue injuries. Wright Medical Group generates the majority of its revenue in the United States.

Ratios

Current vs industry vs history
Forward PE Ratio 119.05
N/A
PB Ratio 3.75
PB Ratio range over the past 10 years
Min: 1.47, Med: 2.42, Max: 5.81
Current: 3.75
1.47
5.81
PS Ratio 3.69
PS Ratio range over the past 10 years
Min: 2.22, Med: 3.56, Max: 5.13
Current: 3.69
2.22
5.13
EV-to-EBIT -4575.79
EV-to-EBIT range over the past 10 years
Min: -5242.5, Med: -22.4, Max: 691
Current: -4575.79
-5242.5
691
EV-to-EBITDA 50.73
EV-to-EBITDA range over the past 10 years
Min: -304.6, Med: -16.5, Max: 640.7
Current: 50.73
-304.6
640.7
EV-to-Revenue 5.05
EV-to-Revenue range over the past 10 years
Min: 2.3, Med: 4.3, Max: 7.2
Current: 5.05
2.3
7.2
Current Ratio 0.91
Current Ratio range over the past 10 years
Min: 0.91, Med: 2.43, Max: 3.29
Current: 0.91
0.91
3.29
Quick Ratio 0.70
Quick Ratio range over the past 10 years
Min: 0.7, Med: 1.44, Max: 1.99
Current: 0.7
0.7
1.99
Days Inventory 351.50
Days Inventory range over the past 10 years
Min: 342.93, Med: 402.04, Max: 530.83
Current: 351.5
342.93
530.83
Days Sales Outstanding 58.32
Days Sales Outstanding range over the past 10 years
Min: 58.32, Med: 69.55, Max: 118.01
Current: 58.32
58.32
118.01
Days Payable 87.58
Days Payable range over the past 10 years
Min: 51.36, Med: 84.7, Max: 105.89
Current: 87.58
51.36
105.89

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -3.10
3-Year Share Buyback Rate range over the past 10 years
Min: -35, Med: -18.85, Max: -3.1
Current: -3.1
-35
-3.1

Valuation & Return

Current vs industry vs history
Price-to-Median-PS-Value 1.03
Price-to-Median-PS-Value range over the past 10 years
Min: 0.67, Med: 1.03, Max: 1.31
Current: 1.03
0.67
1.31
Earnings Yield (Joel Greenblatt) % -0.02
Earnings Yield (Greenblatt) range over the past 10 years
Min: -17.7, Med: -4.3, Max: 0.2
Current: -0.02
-17.7
0.2

More Statistics

Revenue (TTM) (Mil) $ 867.78
EPS (TTM) $ -1.58
Beta 0.72
Volatility % 21.5
52-Week Range $ 24.1 - 32.86
Shares Outstanding (Mil) 126.12

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 4
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y